Clinical Trials Logo

Clinical Trial Summary

The aim of this study was to compare the efficacy and safety of two treatment regimens: argon plasma coagulation (APC) alone and APC in combination with sucralfate administered for chronic hemorrhagic radiation proctopathy.


Clinical Trial Description

Chronic radiation proctopathy (CRP) or proctosigmoiditis is a late complication of pelvic radiotherapy. Symptoms, including diarrhea, rectal bleeding, urgency, and tenesmus, are difficult to treat and adversely impact patient quality of life. Various treatments directed at the reduction of blood loss and improvement of other symptoms have been evaluated, with the most encouraging results reported for two methods: endoscopic argon plasma coagulation (APC) of radiation-induced abnormal vessels in the rectal mucosa, and administration of sucralfate, a drug believed to enhance the mucosal defense and healing when administered orally or rectally. Adequately powered randomized trials comparing various treatments are lacking, and an optimal management strategy has yet to be determined. To address this issue, we conducted a single-center, randomized, placebo-controlled, double-blind study comparing the efficacy and safety of APC alone and APC in combination with sucralfate administered orally. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01613534
Study type Interventional
Source Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology
Contact
Status Completed
Phase Phase 4
Start date June 2003
Completion date June 2007

See also
  Status Clinical Trial Phase
Recruiting NCT06438809 - Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation Proctitis Phase 1/Phase 2
Recruiting NCT03397901 - Transverse Colostomy for Refractory Hemorrhagic Chronic Radiation Proctitis: a Prospective Cohort Study N/A
Not yet recruiting NCT04680195 - Thalidomide in the Treatment of Chronic Radiation Proctitis With Intractable Bleeding Phase 2